Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1
Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Qualitative Stage
St Vincent's Hospital, Sydney
24 participants
Dec 1, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to explore the perceptions of men with prostate cancer (PCa) and high-risk biochemical recurrence (BCR) regarding the risk of breast-related side effects, including gynaecomastia, from treatment.
Eligibility
Inclusion Criteria2
- Men with high-risk BCR PCa but no ADT+/-ARPI experience.
- Men with ADT+/-ARPI experience who have experienced breast-related side effects from this treatment.
Exclusion Criteria1
- Men receiving psychiatric care as a consequence of their prostate cancer diagnosis or treatment thereof.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
this t study will use qualitative methods to explore men's views of gynaecomastia from high-risk BCR PCa treatments (Stage 1) to inform attributes and levels for a later DCE to examine patient treatment preferences (Stage 2).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07552922